Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 881 of 1,261

  1. US 8399428

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  2. US 8399018

    Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  3. US 8399449

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  4. US 8399493

    Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

    Addex Pharmaceuticals S.A. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  5. US 8399501

    Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  6. US 8399537

    Compositions and methods for nail coatings

    Creative Nail Design Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  7. US 8399479

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  8. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  9. US 8399458

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  10. US 8399445

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  11. US 8399472

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  12. US 8399425

    Alleviating neuropathic pain with EETs and sEH inhibitors

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  13. US 8399421

    Treatment for neuropathic pain due to spinal cord injury

    The Board of Regents of the University of Texas System · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  14. US 8399219

    Protease activatable interferon alpha proprotein

    CytomX Therapeutics, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  15. US 8399025

    Polyamine modified particles

    The Board of Regents of the University of Texas System · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  16. US 8399412

    Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  17. US 8398989

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  18. US 8394843

    Substituted isoindoles as glucokinase activators

    Takeda California, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  19. US 8394952

    Dihydrodiazepines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  20. US 8394846

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  21. US 8394762

    Self-decontaminating coatings containing antimicrobial peptides

    United States of America as represented by the Secretary of the Air Force · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  22. US 8394377

    Methods for treating cancer using combination therapy

    The Regents of the University of Colorado · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  23. US 8394966

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  24. US 8394620

    Two-component genome flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.